BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 1805355)

  • 61. Prodromal symptoms of schizophrenia.
    Hopkins RS
    Br J Psychiatry; 1994 Aug; 165(2):268-9. PubMed ID: 7953045
    [No Abstract]   [Full Text] [Related]  

  • 62. Covert visual attention in schizophrenia spectrum personality disordered subjects: visuospatial cuing and alerting effects.
    Moran MJ; Thaker GK; Laporte DJ; Cassady SL; Ross DE
    J Psychiatr Res; 1996; 30(4):261-75. PubMed ID: 8905535
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Nithsdale Schizophrenia Surveys. XII. 'Neurodevelopmental' Schizophrenia: a search for clinical correlates and putative aetiological factors.
    McCreadie RG; Connolly MA; Williamson DJ; Athawes RW; Tilak-Singh D
    Br J Psychiatry; 1994 Sep; 165(3):340-6. PubMed ID: 7994503
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical characteristics of schizotypal-related obsessive-compulsive disorder.
    Poyurovsky M; Faragian S; Pashinian A; Heidrach L; Fuchs C; Weizman R; Koran L
    Psychiatry Res; 2008 May; 159(1-2):254-8. PubMed ID: 18378321
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The genetics of schizophrenia: chromosomal deletions, attentional disturbances, and spectrum boundaries.
    Kendler KS
    Am J Psychiatry; 2003 Sep; 160(9):1549-53. PubMed ID: 12944326
    [No Abstract]   [Full Text] [Related]  

  • 66. Grand rounds: schizophrenia or bipolar?
    Moore JF
    J Am Acad Child Adolesc Psychiatry; 1994 Oct; 33(8):1209-10. PubMed ID: 7982874
    [No Abstract]   [Full Text] [Related]  

  • 67. Defining the schizophrenia spectrum: issues for genetic linkage studies.
    Levinson DF; Mowry BJ
    Schizophr Bull; 1991; 17(3):491-514. PubMed ID: 1947874
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Avoidant personality disorder symptoms in first-degree relatives of schizophrenia patients predict performance on neurocognitive measures: the UCLA family study.
    Fogelson DL; Asarnow RA; Sugar CA; Subotnik KL; Jacobson KC; Neale MC; Kendler KS; Kuppinger H; Nuechterlein KH
    Schizophr Res; 2010 Jul; 120(1-3):113-20. PubMed ID: 20053537
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Early familial and environmental processes in schizophrenia. Importance of premorbid personality evaluation].
    Chabot B; Germain-Robin S; Petit M; Dollfus S
    Encephale; 1998; 24(4):309-14. PubMed ID: 9809235
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder.
    Cadenhead KS; Light GA; Geyer MA; Braff DL
    Am J Psychiatry; 2000 Jan; 157(1):55-9. PubMed ID: 10618013
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Production of interferon-gamma in families with multiple occurrence of schizophrenia.
    Arolt V; Weitzsch C; Wilke I; Nolte A; Pinnow M; Rothermundt M; Kirchner H
    Psychiatry Res; 1997 Feb; 66(2-3):145-52. PubMed ID: 9075278
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Difference in reaction time between subjects with schizotypal and borderline personality disorders.
    Chapin K; Wightman L; Lycaki H; Josef N; Rosenbaum G
    Am J Psychiatry; 1987 Jul; 144(7):948-50. PubMed ID: 3605409
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Overview and summary: twenty-five-year followup of high-risk children.
    Mirsky AF; Kugelmass S; Ingraham LJ; Frenkel E; Nathan M
    Schizophr Bull; 1995; 21(2):227-39. PubMed ID: 7631170
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The New York High-Risk Project: anhedonia, attentional deviance, and psychopathology.
    Erlenmeyer-Kimling L; Cornblatt BA; Rock D; Roberts S; Bell M; West A
    Schizophr Bull; 1993; 19(1):141-53. PubMed ID: 8451608
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The pathophysiology of schizophrenia disorders: perspectives from the spectrum.
    Siever LJ; Davis KL
    Am J Psychiatry; 2004 Mar; 161(3):398-413. PubMed ID: 14992962
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits.
    Cadenhead KS; Swerdlow NR; Shafer KM; Diaz M; Braff DL
    Am J Psychiatry; 2000 Oct; 157(10):1660-8. PubMed ID: 11007721
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Distinguishing mixed anxiety/depression from anxiety and depressive groups using the family history method.
    Reich J
    Compr Psychiatry; 1993; 34(5):285-90. PubMed ID: 8306636
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The specificity of DSM-III schizotypal personality traits.
    Squires-Wheeler E; Skodol AE; Friedman D; Erlenmeyer-Kimling L
    Psychol Med; 1988 Aug; 18(3):757-65. PubMed ID: 3186874
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Schizotypal dimensions: continuity between schizophrenia and bipolar disorders.
    Schürhoff F; Laguerre A; Szöke A; Méary A; Leboyer M
    Schizophr Res; 2005 Dec; 80(2-3):235-42. PubMed ID: 16169190
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Reliability of measuring anomalous experience: the Bonn Scale for the Assessment of Basic Symptoms.
    Vollmer-Larsen A; Handest P; Parnas J
    Psychopathology; 2007; 40(5):345-8. PubMed ID: 17657133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.